Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Continuous or Fixed-Duration Maintenance Therapy in Multiple Myeloma.
Journal: The New England journal of medicine
Published: July 15, 2026
Current experiences with teclistamab in patients with multiple myeloma and renal impairment.
Journal: Expert review of hematology
Published: September 29, 2025
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma.
Journal: Future oncology (London, England)
Published: May 18, 2022
A phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed or relapsed/refractory multiple myeloma: Final analysis of second dose-expansion cohort.
Journal: American journal of hematology
Published: September 15, 2020
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial.
Journal: The Lancet. Oncology
Published: May 13, 2020
Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: February 18, 2019
Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: LYRA study.
Journal: British journal of haematology
Published: October 30, 2018
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
Journal: British journal of haematology
Published: December 22, 2016
Phase 1 Study of Tabalumab, a Human Anti-B-Cell Activating Factor Antibody, and Bortezomib in Patients with Relapsed/Refractory Multiple Myeloma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2016
The challenge of cross-trial comparisons using limited data.
Journal: Haematologica
Published: August 02, 2014
Last Updated: 09/26/2026